Moreover, since EBV infection is correlated with the development of multiple autoimmune diseases, it might be useful to examine the effect of TLR9 inhibition on the progression and severity of other autoimmune diseases associated with EBV infection. This evidence concerns the gene TLR9 and Epstein-Barr virus infection.